Virological response in treatment-naive patients with chronic HCV genotype-1 infection receiving faldaprevir plus pegylated interferon alpha-2a and ribavirin is unaffected by ribavirin dose reduction

Identifiers
Identifiers
Date issued
2014Journal title
JOURNAL OF HEPATOLOGY
Type of content
Publicación de congreso
